Evidence map›Paper›PMID 30954453›Full record

ArticleInternational journal for parasitology2019

Highly heterogeneous residual malaria risk in western Thailand.

Wang Nguitragool, Stephan Karl, Michael White, Cristian Koepfli, Ingrid Felger, Pratap Singhasivanon, Ivo Mueller, Jetsumon Sattabongkot

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal for parasitology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Epidemiology of malaria and leishmaniasis in Thailand (2004-2025): A systematic review.Current research in parasitology & vector-borne diseases · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wang NguitragoolDepartment of Molecular Tropical Medicine & Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Stephan KarlPopulation Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia; Vector-borne Diseases Unit, Papua New Guinea Institute of Medical Research, Madang, Madang Province, Papua New Guinea.
Michael WhiteMalaria: Parasites and Hosts Unit, Department of Parasites & Insect Vectors, Institute Pasteur, Paris, France.
Cristian KoepfliPopulation Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.
Ingrid FelgerDepartment of Medical Parasitology and Infection Biology, Swiss Tropical & Public Health Institute, Basel, Switzerland.
Pratap SinghasivanonDepartment of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Ivo MuellerPopulation Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia; Malaria: Parasites and Hosts Unit, Department of Parasites & Insect Vectors, Institute Pasteur, Paris, France. Electronic address: mueller@wehi.edu.au.
Jetsumon SattabongkotMahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. Electronic address: jetsumon.pra@mahidol.ac.th.

Funding

Discovery & validation of novel P. vivax antigens for identification and monitoriR01AI104822 · NIAID · MAHIDOL UNIVERSITY · PI PRACHUMSRI, JETSUMON · 2013 to 2017
$672k
NIAID NIH HHS R01 AI104822Wellcome TrustWellcome Trust 101073/Z/13Z
6 · The paper itself

Abstract

Over the past decades, the malaria burden in Thailand has substantially declined. Most infections now originate from the national border regions. In these areas, the prevalence of asymptomatic infections is still substantial and poses a challenge for the national malaria elimination program. To determine epidemiological parameters as well as risk factors for malaria infection in western Thailand, we carried out a cohort study in Kanchanaburi and Ratchaburi provinces on the Thailand-Myanmar border. Blood samples from 999 local participants were examined for malaria infection every 4 weeks between May 2013 and Jun 2014. Prevalence of Plasmodium falciparum and Plasmodium vivax was determined by quantitative PCR (qPCR) and showed a seasonal variation with values fluctuating from 1.7% to 4.2% for P. vivax and 0% to 1.3% for P. falciparum. Ninety percent of infections were asymptomatic. The annual molecular force of blood-stage infection (

Indexed as

AdolescentAdultAgedAged, 80 and overAnimalsAnophelesChildChild, PreschoolCohort StudiesCross-Sectional StudiesFarmersFemaleHumansIncidenceInfantLongitudinal StudiesEpidemiologyForce of infectionIncidenceMalariaPlasmodium falciparumPlasmodium vivaxPrevalenceThailand

Identifiers

PMID30954453
PMCPMC6996282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.